abstract |
Provided are compounds of formula (I) or pharmaceutically acceptable salts, solvates, active metabolites, polymorphs, isotopic markers, isomers or prodrugs thereof and their applications. The compound has a strong inhibitory effect on both the activity of FGFR4 kinase and the proliferative activity of Hep 3B cells that express high FGFR4. |